Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Hungary Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20103
20121
20134
20181
20193
20201
20211
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Incyte Corporation2
Merck Sharp & Dohme LLC2
Boehringer Ingelheim1
Cardiovascular and Interventional Radiological Society of Europe1
Eli Lilly and Company1
Exelixis1
Hoffmann-La Roche1
Kymab Limited1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular20
Carcinoma, Non-Small-Cell Lung5
Carcinoma, Renal Cell3
Melanoma3
Carcinoma2
Neoplasm Metastasis2
Carcinoma, Transitional Cell1
Colorectal Neoplasms1
Cutaneous Squamous Cell Carcinoma1
Esophageal Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.